Corundum Systems Biology is an investment and research-focused company that advances health by applying systems biology, data-driven discovery, and high-throughput technologies to accelerate breakthroughs in life sciences. The organization supports ventures and translational efforts that decode human biology in real time, aiming to develop predictive, preventative, and personalized health solutions. Headquartered in Tokyo with a presence in North America, the firm partners with academic labs, biotech founders, and pharma leaders to drive clinically impactful innovations.
No recent news for this company.